UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 15.828

Sortiert nach

Estimating (quality‐adjusted) life‐year losses associated with deaths: With application to COVID‐19

Health economics, 2021-03, Vol.30 (3), p.699-707

2021

Link zum Volltext

Verfügbarkeit prüfen

QALYs: The Basics

Value in health, 2009-03, Vol.12 (s1), p.S5-S9

2009

Link zum Volltext

Verfügbarkeit prüfen

Alternatives to the quality‐adjusted life year: How well do they address common criticisms?

Health services research, 2023-04, Vol.58 (2), p.433-444

2023

Link zum Volltext

Verfügbarkeit prüfen

An Empiric Estimate of the Value of Life: Updating the Renal Dialysis Cost-Effectiveness Standard

Value in health, 2009, Vol.12 (1), p.80-87

2009

Link zum Volltext

Verfügbarkeit prüfen

Mapping the EORTC QLQ C-30 onto the EQ-5D Instrument: The Potential to Estimate QALYs without Generic Preference Data

Value in health, 2009, Vol.12 (1), p.167-171

2009

Link zum Volltext

Verfügbarkeit prüfen

The QALY at 50: One story many voices

Social science & medicine (1982), 2022-03, Vol.296, p.114653-114653, Article 114653

2022

Link zum Volltext

Verfügbarkeit prüfen

Mapping to Obtain EQ-5D Utility Values for Use in NICE Health Technology Assessments

Value in health, 2013-01, Vol.16 (1), p.202-210

2013

Link zum Volltext

Verfügbarkeit prüfen

Cost‐effectiveness of incisional negative pressure wound therapy compared with standard care after caesarean section in obese women: a trial‐based economic evaluation

BJOG : an international journal of obstetrics and gynaecology, 2019-04, Vol.126 (5), p.619-627

2019

Link zum Volltext

Verfügbarkeit prüfen

Retaining, and Enhancing, the QALY

Value in health, 2009-03, Vol.12 (s1), p.S18-S26

2009

Link zum Volltext

Verfügbarkeit prüfen

Disentangling WTP per QALY data: different analytical approaches, different answers

Health economics, 2012-03, Vol.21 (3), p.222-237

2012

Link zum Volltext

Verfügbarkeit prüfen

Cost‐utility of omalizumab for the treatment of uncontrolled moderate‐to‐severe persistent pediatric allergic asthma in a middle‐income country

Pediatric pulmonology, 2021-09, Vol.56 (9), p.2987-2996

2021

Link zum Volltext

Verfügbarkeit prüfen

Opioid agonist treatment reduces losses in quality of life and quality-adjusted life expectancy in heroin users: Evidence from real world data

Drug and alcohol dependence, 2019-08, Vol.201, p.197-204

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost‐effectiveness of extended release naltrexone to prevent relapse among criminal justice‐involved individuals with a history of opioid use disorder

Addiction (Abingdon, England), 2017-08, Vol.112 (8), p.1440-1450

2017

Link zum Volltext

Verfügbarkeit prüfen

The value of health—Empirical issues when estimating the monetary value of a quality‐adjusted life year based on well‐being data

Health economics, 2021-08, Vol.30 (8), p.1849-1870

2021

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom

Value in health, 2018-04, Vol.21 (4), p.407-415

2018

Link zum Volltext

Verfügbarkeit prüfen

Cost effectiveness of regorafenib as second‐line therapy for patients with advanced hepatocellular carcinoma

Cancer, 2017-10, Vol.123 (19), p.3725-3731

2017

Link zum Volltext

Verfügbarkeit prüfen

Consistent valuation of a reduction in mortality risk using values per life, life year, and quality‐adjusted life year

Health economics, 2023-09, Vol.32 (9), p.1964-1981

Hammitt, James K.

2023

Link zum Volltext

Verfügbarkeit prüfen

Moving the QALY Forward: Rationale for Change

Value in health, 2009-03, Vol.12 (s1), p.S1-S4

2009

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Primary and Revision Surgery for Adult Spinal Deformity

Spine (Philadelphia, Pa. 1976), 2018-06, Vol.43 (11), p.791-797

2018

Link zum Volltext

Verfügbarkeit prüfen

Cost‐effectiveness of screening for HLA‐B1502 prior to initiation of carbamazepine in epilepsy patients of Asian ancestry in the United States

Epilepsia (Copenhagen), 2019-07, Vol.60 (7), p.1472-1481

2019

Link zum Volltext

Verfügbarkeit prüfen

A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions

Value in health, 2021-11, Vol.24 (11), p.1651-1659

2021

Link zum Volltext

Verfügbarkeit prüfen

Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis

Cancer, 2016-11, Vol.122 (21), p.3386-3393

2016

Link zum Volltext

Verfügbarkeit prüfen

Burden of osteoporosis and costs associated with human biomonitored cadmium exposure in three European countries: France, Spain and Belgium

International journal of hygiene and environmental health, 2021-05, Vol.234, p.113747, Article 113747

2021

Link zum Volltext

Verfügbarkeit prüfen

Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality‐adjusted life‐year analysis

Cancer, 2016-04, Vol.122 (7), p.1085-1096

2016

Link zum Volltext

Verfügbarkeit prüfen

Cost‐effectiveness of a pragmatic exercise intervention for women with breast cancer: results from a randomized controlled trial

Psycho-oncology (Chichester, England), 2017-05, Vol.26 (5), p.649-655

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 15.828

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14.970)
Mit Volltextzugriff
(13.369)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(14.615)
IngentaConnect
(8.243)
Journals@Ovid Complete
(7.899)
EZB Free E-Journals
(7.404)
IngentaConnect Journals
(4.421)
Elsevier ScienceDirect Journals Complete
(3.565)
Wiley Online Library
(2.838)
Springer Nature - Complete Springer Journals
(2.761)
Single Journals
(2.460)
Applied Social Sciences Index & Abstracts (ASSIA)
(1.847)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.462)
Wiley Online Library Full Collection 2018
(1.324)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.128)
JSTOR Complete Journals
(950)
Taylor & Francis Current Content Access
(862)
Nexis Uni
(706)
BMJ
(675)
Taylor & Francis Journals Complete
(672)
Sage Journals
(648)
Oxford Journals
(639)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Value In Health
(1.095)
Pharmacoeconomics
(497)
Health Technology Assessment
(376)
Plos One
(327)
Journal Of Medical Economics
(310)
Medical Decision Making
(293)
Health Economics
(253)
Bmj Open
(203)
The European Journal Of Health Economics
(201)
Expert Review Of Pharmacoeconomics & Outcomes Research
(170)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(131)
... seit 30 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Estimating (quality‐adjusted) life‐year losses associated with deaths: With application to COVID‐19

QALYs: The Basics

Alternatives to the quality‐adjusted life year: How well do they address common criticisms?

An Empiric Estimate of the Value of Life: Updating the Renal Dialysis Cost-Effectiveness Standard

Mapping the EORTC QLQ C-30 onto the EQ-5D Instrument: The Potential to Estimate QALYs without Generic Preference Data

The QALY at 50: One story many voices

Mapping to Obtain EQ-5D Utility Values for Use in NICE Health Technology Assessments

Cost‐effectiveness of incisional negative pressure wound therapy compared with standard care after caesarean section in obese women: a trial‐based economic evaluation

Retaining, and Enhancing, the QALY

Disentangling WTP per QALY data: different analytical approaches, different answers

Cost‐utility of omalizumab for the treatment of uncontrolled moderate‐to‐severe persistent pediatric allergic asthma in a middle‐income country

Opioid agonist treatment reduces losses in quality of life and quality-adjusted life expectancy in heroin users: Evidence from real world data

Cost‐effectiveness of extended release naltrexone to prevent relapse among criminal justice‐involved individuals with a history of opioid use disorder

The value of health—Empirical issues when estimating the monetary value of a quality‐adjusted life year based on well‐being data

Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom

Cost effectiveness of regorafenib as second‐line therapy for patients with advanced hepatocellular carcinoma

Consistent valuation of a reduction in mortality risk using values per life, life year, and quality‐adjusted life year

Moving the QALY Forward: Rationale for Change

Cost-Effectiveness of Primary and Revision Surgery for Adult Spinal Deformity

Cost‐effectiveness of screening for HLA‐B1502 prior to initiation of carbamazepine in epilepsy patients of Asian ancestry in the United States

A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions

Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis

Burden of osteoporosis and costs associated with human biomonitored cadmium exposure in three European countries: France, Spain and Belgium

Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality‐adjusted life‐year analysis

Cost‐effectiveness of a pragmatic exercise intervention for women with breast cancer: results from a randomized controlled trial

Suchergebnisse filtern